Trends in Enzyme Inhibition and Activation in Drug Design - Part II

Author(s): Athina Geronikaki.

Journal Name: Current Topics in Medicinal Chemistry

Volume 19 , Issue 5 , 2019

Become EABM
Become Reviewer

[1]
Dmitriev, A.V.; Lagunin, A.A.; Karasev, D.A.; Rudik, A.V.; Pogodin, P.V.; Filimonov, D.A.; Poroikov, V.V. Prediction of drug-drug interactions related to inhibition or induction of drug-metabolizing enzymes. Curr. Top. Med. Chem., 2019, 19(5), 319-336.
[PMID: 30674264]
[2]
Saxena, A.K.; Singh, A. Mycobacterial tuberculosis enzyme targets and their inhibitors. Curr. Top. Med. Chem, 2019, 19(5), 337-355.
[3]
Tratrat, C.; Haroun, M.; Xenikakis, I.; Liaras, K.; Tsolaki, E.; Eleftheriou, P.; Petrou, A.; Aldhubiab, B.; Attimarad, M.; Venugopala, K.N.; Harsha, S.; Elsewedy, H.S.; Geronikaki, A. Soković, M. Design, synthesis, evaluation of antimicrobial activity and docking studies of new thiazole-based chalcones. Curr. Top. Med. Chem, 2019, 19(5), 356-375.
[4]
Jangra, S.; Purushothaman, G.; Juvale, K.; Ravi, S.; Menon, A.; Kirubakaran, S.; Thiruvenkatam, V. Synthesis and in vitro enzymatic studies of new 3-aryldiazenyl indoles as promising Helicobacter pylori IMPDH inhibitors. Curr. Top. Med. Chem., 2019, 19(5), 376-382.
[PMID: 30827248]
[5]
Eleftheriou, P.; Therianou, E.; Lazari, D.; Dirnali, S.; Micha, A. Docking assisted prediction and biological evaluation of sideritis l. components with PTP1B inhibitory action and probable anti-diabetic properties. Curr. Top. Med. Chem, 2019, 19(5), 383-392.
[PMID: 30806317]


Rights & PermissionsPrintExport Cite as


Article Details

VOLUME: 19
ISSUE: 5
Year: 2019
Page: [317 - 318]
Pages: 2
DOI: 10.2174/156802661905190418152713

Article Metrics

PDF: 21
HTML: 4
EPUB: 1